[23] Targeted delivery of antisense oligonucleotides to parenchymal liver cells in vivo

Oligodeoxynucleotides (ODNs) inhibit gene expression at various levels both in vitro and in vivo. In vivo, the efficacy of ODN-induced regulation of genes in specific cell types may be suboptimal owing to poor accumulation of ODNs in these cells. In addition, untimely elimination of ODNs through ren...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Methods in Enzymology 2000, Vol.314, p.324-342
Hauptverfasser: Biessen, E.A.L., Vietsch, H., Rump, E.T., Fluiter, K., Busterbosch, M.K., van Berkel, T.J.C.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 342
container_issue
container_start_page 324
container_title Methods in Enzymology
container_volume 314
creator Biessen, E.A.L.
Vietsch, H.
Rump, E.T.
Fluiter, K.
Busterbosch, M.K.
van Berkel, T.J.C.
description Oligodeoxynucleotides (ODNs) inhibit gene expression at various levels both in vitro and in vivo. In vivo, the efficacy of ODN-induced regulation of genes in specific cell types may be suboptimal owing to poor accumulation of ODNs in these cells. In addition, untimely elimination of ODNs through renal clearance, degradation, and scavenger receptor-mediated uptake may further impair their therapeutic activity. These hurdles can be at least partly overcome by targeted delivery of the ODNs to the desired site of action. As short (and in particular uncharged) oligothymidinylates are poor substrates for hepatic scavenger receptors that are responsible for the rapid elimination of ODNs by cells of the reticuloendothelial system, the results leave unanswered whether longer, charged, and miscellaneous ODN sequences can also be redirected to the aimed target cell in vivo. In this respect, it is crucial to analyze the tissue distribution and identify the cellular uptake sites within the liver, using full-length antisense sequences. In the study described in the chapter, in vivo evidence is provided that untimely elimination of a miscellaneous 20-mer ODN by the preceding scavenger pathways can be circumvented and, concomitantly, accumulation by parenchymal liver cells can be enhanced after derivatization with a small-sized synthetic galactoside with high affinity for the asialoglycoprotein receptor.
doi_str_mv 10.1016/S0076-6879(99)14113-2
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_70799091</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0076687999141132</els_id><sourcerecordid>70799091</sourcerecordid><originalsourceid>FETCH-LOGICAL-c315t-c66e6069e2582caf1e23466a241de8a3e0829a60e7f32ac63a923d55abab7adf3</originalsourceid><addsrcrecordid>eNo9kUtLAzEUhYMPtNb-BCUr0cVoHs1rJSK-QHBhxYVISJM7NTKd1Mm00H_v9KGru_nO4dxzEDqh5JISKq9eCVGykFqZc2Mu6JBSXrAd1KNCqEIZrXfRwChNKKOaMSrkHur9Sw7RUc7fhDClDT1Ah5QIKQjjPfT-wfgnHrlmAi0EHKCKC2iWOJXY1W3MUGfAqYqTVM99BamNATJuE565Bmr_tZy6Cq812ENVZRxrvIiLdIz2S1dlGGxvH73d341uH4vnl4en25vnwnMq2sJLCZJIA0xo5l1JgfGhlI4NaQDtOBDNjJMEVMmZ85I7w3gQwo3dWLlQ8j462_jOmvQzh9zaacyrJK6GNM9WEWUMMbQDT7fgfDyFYGdNnLpmaf-q6IDrDQBd3EWExmYfuxchxAZ8a0OKHWxXY9j1GHbVrDXGrsewjP8CaqJ5Mw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70799091</pqid></control><display><type>article</type><title>[23] Targeted delivery of antisense oligonucleotides to parenchymal liver cells in vivo</title><source>MEDLINE</source><source>ScienceDirect eBooks</source><source>Access via ScienceDirect (Elsevier)</source><creator>Biessen, E.A.L. ; Vietsch, H. ; Rump, E.T. ; Fluiter, K. ; Busterbosch, M.K. ; van Berkel, T.J.C.</creator><creatorcontrib>Biessen, E.A.L. ; Vietsch, H. ; Rump, E.T. ; Fluiter, K. ; Busterbosch, M.K. ; van Berkel, T.J.C.</creatorcontrib><description>Oligodeoxynucleotides (ODNs) inhibit gene expression at various levels both in vitro and in vivo. In vivo, the efficacy of ODN-induced regulation of genes in specific cell types may be suboptimal owing to poor accumulation of ODNs in these cells. In addition, untimely elimination of ODNs through renal clearance, degradation, and scavenger receptor-mediated uptake may further impair their therapeutic activity. These hurdles can be at least partly overcome by targeted delivery of the ODNs to the desired site of action. As short (and in particular uncharged) oligothymidinylates are poor substrates for hepatic scavenger receptors that are responsible for the rapid elimination of ODNs by cells of the reticuloendothelial system, the results leave unanswered whether longer, charged, and miscellaneous ODN sequences can also be redirected to the aimed target cell in vivo. In this respect, it is crucial to analyze the tissue distribution and identify the cellular uptake sites within the liver, using full-length antisense sequences. In the study described in the chapter, in vivo evidence is provided that untimely elimination of a miscellaneous 20-mer ODN by the preceding scavenger pathways can be circumvented and, concomitantly, accumulation by parenchymal liver cells can be enhanced after derivatization with a small-sized synthetic galactoside with high affinity for the asialoglycoprotein receptor.</description><identifier>ISSN: 0076-6879</identifier><identifier>ISBN: 9780121822156</identifier><identifier>ISBN: 012182215X</identifier><identifier>EISSN: 1557-7988</identifier><identifier>DOI: 10.1016/S0076-6879(99)14113-2</identifier><identifier>PMID: 10565023</identifier><language>eng</language><publisher>United States: Elsevier Science &amp; Technology</publisher><subject>Animals ; Asialoglycoproteins - metabolism ; Biological Availability ; Drug Carriers ; Drug Delivery Systems - methods ; Drug Stability ; Glycopeptides ; Liver - cytology ; Liver - drug effects ; Membrane Proteins ; Oligodeoxyribonucleotides, Antisense - administration &amp; dosage ; Oligodeoxyribonucleotides, Antisense - chemistry ; Oligodeoxyribonucleotides, Antisense - pharmacokinetics ; Orosomucoid - metabolism ; Rats ; Receptors, Immunologic - metabolism ; Receptors, Lipoprotein ; Receptors, Scavenger ; Scavenger Receptors, Class B</subject><ispartof>Methods in Enzymology, 2000, Vol.314, p.324-342</ispartof><rights>2000</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c315t-c66e6069e2582caf1e23466a241de8a3e0829a60e7f32ac63a923d55abab7adf3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0076687999141132$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,780,781,785,794,3460,3551,4025,11293,27928,27929,27930,45815,46000</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10565023$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Biessen, E.A.L.</creatorcontrib><creatorcontrib>Vietsch, H.</creatorcontrib><creatorcontrib>Rump, E.T.</creatorcontrib><creatorcontrib>Fluiter, K.</creatorcontrib><creatorcontrib>Busterbosch, M.K.</creatorcontrib><creatorcontrib>van Berkel, T.J.C.</creatorcontrib><title>[23] Targeted delivery of antisense oligonucleotides to parenchymal liver cells in vivo</title><title>Methods in Enzymology</title><addtitle>Methods Enzymol</addtitle><description>Oligodeoxynucleotides (ODNs) inhibit gene expression at various levels both in vitro and in vivo. In vivo, the efficacy of ODN-induced regulation of genes in specific cell types may be suboptimal owing to poor accumulation of ODNs in these cells. In addition, untimely elimination of ODNs through renal clearance, degradation, and scavenger receptor-mediated uptake may further impair their therapeutic activity. These hurdles can be at least partly overcome by targeted delivery of the ODNs to the desired site of action. As short (and in particular uncharged) oligothymidinylates are poor substrates for hepatic scavenger receptors that are responsible for the rapid elimination of ODNs by cells of the reticuloendothelial system, the results leave unanswered whether longer, charged, and miscellaneous ODN sequences can also be redirected to the aimed target cell in vivo. In this respect, it is crucial to analyze the tissue distribution and identify the cellular uptake sites within the liver, using full-length antisense sequences. In the study described in the chapter, in vivo evidence is provided that untimely elimination of a miscellaneous 20-mer ODN by the preceding scavenger pathways can be circumvented and, concomitantly, accumulation by parenchymal liver cells can be enhanced after derivatization with a small-sized synthetic galactoside with high affinity for the asialoglycoprotein receptor.</description><subject>Animals</subject><subject>Asialoglycoproteins - metabolism</subject><subject>Biological Availability</subject><subject>Drug Carriers</subject><subject>Drug Delivery Systems - methods</subject><subject>Drug Stability</subject><subject>Glycopeptides</subject><subject>Liver - cytology</subject><subject>Liver - drug effects</subject><subject>Membrane Proteins</subject><subject>Oligodeoxyribonucleotides, Antisense - administration &amp; dosage</subject><subject>Oligodeoxyribonucleotides, Antisense - chemistry</subject><subject>Oligodeoxyribonucleotides, Antisense - pharmacokinetics</subject><subject>Orosomucoid - metabolism</subject><subject>Rats</subject><subject>Receptors, Immunologic - metabolism</subject><subject>Receptors, Lipoprotein</subject><subject>Receptors, Scavenger</subject><subject>Scavenger Receptors, Class B</subject><issn>0076-6879</issn><issn>1557-7988</issn><isbn>9780121822156</isbn><isbn>012182215X</isbn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kUtLAzEUhYMPtNb-BCUr0cVoHs1rJSK-QHBhxYVISJM7NTKd1Mm00H_v9KGru_nO4dxzEDqh5JISKq9eCVGykFqZc2Mu6JBSXrAd1KNCqEIZrXfRwChNKKOaMSrkHur9Sw7RUc7fhDClDT1Ah5QIKQjjPfT-wfgnHrlmAi0EHKCKC2iWOJXY1W3MUGfAqYqTVM99BamNATJuE565Bmr_tZy6Cq812ENVZRxrvIiLdIz2S1dlGGxvH73d341uH4vnl4en25vnwnMq2sJLCZJIA0xo5l1JgfGhlI4NaQDtOBDNjJMEVMmZ85I7w3gQwo3dWLlQ8j462_jOmvQzh9zaacyrJK6GNM9WEWUMMbQDT7fgfDyFYGdNnLpmaf-q6IDrDQBd3EWExmYfuxchxAZ8a0OKHWxXY9j1GHbVrDXGrsewjP8CaqJ5Mw</recordid><startdate>2000</startdate><enddate>2000</enddate><creator>Biessen, E.A.L.</creator><creator>Vietsch, H.</creator><creator>Rump, E.T.</creator><creator>Fluiter, K.</creator><creator>Busterbosch, M.K.</creator><creator>van Berkel, T.J.C.</creator><general>Elsevier Science &amp; Technology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>2000</creationdate><title>[23] Targeted delivery of antisense oligonucleotides to parenchymal liver cells in vivo</title><author>Biessen, E.A.L. ; Vietsch, H. ; Rump, E.T. ; Fluiter, K. ; Busterbosch, M.K. ; van Berkel, T.J.C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c315t-c66e6069e2582caf1e23466a241de8a3e0829a60e7f32ac63a923d55abab7adf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Animals</topic><topic>Asialoglycoproteins - metabolism</topic><topic>Biological Availability</topic><topic>Drug Carriers</topic><topic>Drug Delivery Systems - methods</topic><topic>Drug Stability</topic><topic>Glycopeptides</topic><topic>Liver - cytology</topic><topic>Liver - drug effects</topic><topic>Membrane Proteins</topic><topic>Oligodeoxyribonucleotides, Antisense - administration &amp; dosage</topic><topic>Oligodeoxyribonucleotides, Antisense - chemistry</topic><topic>Oligodeoxyribonucleotides, Antisense - pharmacokinetics</topic><topic>Orosomucoid - metabolism</topic><topic>Rats</topic><topic>Receptors, Immunologic - metabolism</topic><topic>Receptors, Lipoprotein</topic><topic>Receptors, Scavenger</topic><topic>Scavenger Receptors, Class B</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Biessen, E.A.L.</creatorcontrib><creatorcontrib>Vietsch, H.</creatorcontrib><creatorcontrib>Rump, E.T.</creatorcontrib><creatorcontrib>Fluiter, K.</creatorcontrib><creatorcontrib>Busterbosch, M.K.</creatorcontrib><creatorcontrib>van Berkel, T.J.C.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Methods in Enzymology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Biessen, E.A.L.</au><au>Vietsch, H.</au><au>Rump, E.T.</au><au>Fluiter, K.</au><au>Busterbosch, M.K.</au><au>van Berkel, T.J.C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>[23] Targeted delivery of antisense oligonucleotides to parenchymal liver cells in vivo</atitle><jtitle>Methods in Enzymology</jtitle><addtitle>Methods Enzymol</addtitle><date>2000</date><risdate>2000</risdate><volume>314</volume><spage>324</spage><epage>342</epage><pages>324-342</pages><issn>0076-6879</issn><eissn>1557-7988</eissn><isbn>9780121822156</isbn><isbn>012182215X</isbn><abstract>Oligodeoxynucleotides (ODNs) inhibit gene expression at various levels both in vitro and in vivo. In vivo, the efficacy of ODN-induced regulation of genes in specific cell types may be suboptimal owing to poor accumulation of ODNs in these cells. In addition, untimely elimination of ODNs through renal clearance, degradation, and scavenger receptor-mediated uptake may further impair their therapeutic activity. These hurdles can be at least partly overcome by targeted delivery of the ODNs to the desired site of action. As short (and in particular uncharged) oligothymidinylates are poor substrates for hepatic scavenger receptors that are responsible for the rapid elimination of ODNs by cells of the reticuloendothelial system, the results leave unanswered whether longer, charged, and miscellaneous ODN sequences can also be redirected to the aimed target cell in vivo. In this respect, it is crucial to analyze the tissue distribution and identify the cellular uptake sites within the liver, using full-length antisense sequences. In the study described in the chapter, in vivo evidence is provided that untimely elimination of a miscellaneous 20-mer ODN by the preceding scavenger pathways can be circumvented and, concomitantly, accumulation by parenchymal liver cells can be enhanced after derivatization with a small-sized synthetic galactoside with high affinity for the asialoglycoprotein receptor.</abstract><cop>United States</cop><pub>Elsevier Science &amp; Technology</pub><pmid>10565023</pmid><doi>10.1016/S0076-6879(99)14113-2</doi><tpages>19</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0076-6879
ispartof Methods in Enzymology, 2000, Vol.314, p.324-342
issn 0076-6879
1557-7988
language eng
recordid cdi_proquest_miscellaneous_70799091
source MEDLINE; ScienceDirect eBooks; Access via ScienceDirect (Elsevier)
subjects Animals
Asialoglycoproteins - metabolism
Biological Availability
Drug Carriers
Drug Delivery Systems - methods
Drug Stability
Glycopeptides
Liver - cytology
Liver - drug effects
Membrane Proteins
Oligodeoxyribonucleotides, Antisense - administration & dosage
Oligodeoxyribonucleotides, Antisense - chemistry
Oligodeoxyribonucleotides, Antisense - pharmacokinetics
Orosomucoid - metabolism
Rats
Receptors, Immunologic - metabolism
Receptors, Lipoprotein
Receptors, Scavenger
Scavenger Receptors, Class B
title [23] Targeted delivery of antisense oligonucleotides to parenchymal liver cells in vivo
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-11T19%3A26%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=%5B23%5D%20Targeted%20delivery%20of%20antisense%20oligonucleotides%20to%20parenchymal%20liver%20cells%20in%20vivo&rft.jtitle=Methods%20in%20Enzymology&rft.au=Biessen,%20E.A.L.&rft.date=2000&rft.volume=314&rft.spage=324&rft.epage=342&rft.pages=324-342&rft.issn=0076-6879&rft.eissn=1557-7988&rft.isbn=9780121822156&rft.isbn_list=012182215X&rft_id=info:doi/10.1016/S0076-6879(99)14113-2&rft_dat=%3Cproquest_pubme%3E70799091%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70799091&rft_id=info:pmid/10565023&rft_els_id=S0076687999141132&rfr_iscdi=true